| Monkeypox |
0 |
1 |
| Outbreak |
0 |
0.99 |
| Genomic Medicine |
0 |
0.16 |
| COVID-19 |
0 |
0.12 |
| Acute Respiratory Distress Syndrome |
0 |
0.08 |
| Antiviral Agents |
0 |
0.08 |
| Apolipoproteins |
0 |
0.08 |
| Biologic Therapy |
0 |
0.08 |
| Biomedical Technology |
0 |
0.08 |
| Cardiovascular Risk Management |
0 |
0.08 |
| DNA Sequencing |
0 |
0.08 |
| Genetics |
0 |
0.08 |
| Healthcare and Medical Technology |
0 |
0.08 |
| Lipids Management |
0 |
0.08 |
| Massachusetts |
0 |
0.08 |
| Severe Acute Respiratory Syndrome |
0 |
0.08 |